Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Vanderbilt scientists contribute to finding that could lead to the first effective RSV vaccine

07.02.2014
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.

The Vanderbilt scientists and others analyzed in an animal model a new method developed at The Scripps Research Institute (TSRI) in La Jolla, Calif., for designing artificial proteins capable of stimulating an immune response against RSV.

The virus, which worldwide causes nearly 7 percent of all deaths among children ages 1 month to 1 year and is the leading cause of hospitalizations among children under 2, has been notoriously resistant to vaccine-design strategies.

"This project is the first work in which a protein that was designed on a computer has been shown to work as a vaccine candidate for a human pathogen," said Vanderbilt's James Crowe, M.D., Ann Scott Carell Professor and a leading RSV researcher.

"We believe this will be one of the principal ways that vaccines are designed and made in the future," said Crowe, also professor of Pediatrics and Pathology, Microbiology and Immunology.

TSRI scientists, led by senior author William Schief, Ph.D., used a "rational design" approach that focused on specific binding areas (epitopes) on the virus.

Virtually all existing viral vaccines use whole (killed or weakened) virus particles or entire viral proteins to stimulate antibody reactions. These vaccines display virtually the same large set of viral epitopes that the immune system would encounter during a natural infection. Yet some viruses, including RSV, conceal their vulnerable epitopes.

Scientists can sift through blood samples of virus-exposed patients to find the rare, "broadly neutralizing" antibodies that hit those vulnerable epitopes. They also know how to map the precise atomic structures of these antibodies and their corresponding epitopes using X-ray crystallography.

"What we haven't been able to do is to take that information about broadly neutralizing antibodies and their epitopes and translate it into effective, epitope-focused vaccines," lead author Bruno Correia, Ph.D., a member of the Schief laboratory at the time of the study, said in a news release.

The TSRI scientists developed a new software app, "Fold from Loops," to design proteins that folded around their functional fragments more naturally in a way that mimicked the viral epitope and which could serve as a key component of an effective vaccine.

In rhesus macaque monkeys, whose immune systems are quite similar to humans,' the designer "immunogen" proteins showed great promise. After five immunizations, 12 of 16 monkeys were producing robust amounts of antibodies that could neutralize RSV in the lab dish.

Analyses of the animals' immune responses were performed in the laboratories of Philip Johnson, M.D., at Children's Hospital in Philadelphia, and by Crowe and postdoctoral fellow John T. Bates, Ph.D., in the Vanderbilt Vaccine Center, which Crowe directs.

Former Vanderbilt faculty member Barney Graham, M.D., Ph.D., chief of the Viral Pathogenesis Laboratory at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, also participated in the analyses.

Having proven the principle of epitope-specific design, Schief and his colleagues now hope to produce a working RSV vaccine. "We're also trying to improve this protein design method further and apply it to other vaccine projects, including HIV and influenza vaccines," he said in a news release.

Craig Boerner | Vanderbilt University
Further information:
http://www.vanderbilt.edu

More articles from Life Sciences:

nachricht Pathogenic bacteria hitchhiking to North and Baltic Seas?
22.07.2016 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung

nachricht Unconventional quasiparticles predicted in conventional crystals
22.07.2016 | Max-Planck-Institut für Chemische Physik fester Stoffe

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Newly discovered material property may lead to high temp superconductivity

Researchers at the U.S. Department of Energy's (DOE) Ames Laboratory have discovered an unusual property of purple bronze that may point to new ways to achieve high temperature superconductivity.

While studying purple bronze, a molybdenum oxide, researchers discovered an unconventional charge density wave on its surface.

Im Focus: Mapping electromagnetic waveforms

Munich Physicists have developed a novel electron microscope that can visualize electromagnetic fields oscillating at frequencies of billions of cycles per second.

Temporally varying electromagnetic fields are the driving force behind the whole of electronics. Their polarities can change at mind-bogglingly fast rates, and...

Im Focus: Continental tug-of-war - until the rope snaps

Breakup of continents with two speed: Continents initially stretch very slowly along the future splitting zone, but then move apart very quickly before the onset of rupture. The final speed can be up to 20 times faster than in the first, slow extension phase.phases

Present-day continents were shaped hundreds of millions of years ago as the supercontinent Pangaea broke apart. Derived from Pangaea’s main fragments Gondwana...

Im Focus: A Peek into the “Birthing Room” of Ribosomes

Scaffolding and specialised workers help with the delivery – Heidelberg biochemists gain new insights into biogenesis

A type of scaffolding on which specialised workers ply their trade helps in the manufacturing process of the two subunits from which the ribosome – the protein...

Im Focus: New protocol enables analysis of metabolic products from fixed tissues

Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples. Their findings, published in the journal Nature Protocols, explain the new access to metabolic information, which will offer previously unexploited potential for tissue-based research and molecular diagnostics.

In biomedical research, working with tissue samples is indispensable because it permits insights into the biological reality of patients, for example, in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

GROWING IN CITIES - Interdisciplinary Perspectives on Urban Gardening

15.07.2016 | Event News

SIGGRAPH2016 Computer Graphics Interactive Techniques, 24-28 July, Anaheim, California

15.07.2016 | Event News

Partner countries of FAIR accelerator meet in Darmstadt and approve developments

11.07.2016 | Event News

 
Latest News

The Exception and its Rules

25.07.2016 | Physics and Astronomy

Using Ultrashort Pulsed Laser Radiation to Process Fibre-Reinforced Components

25.07.2016 | Materials Sciences

Added bacterial film makes new mortar resistant to water uptake

25.07.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>